Otsuka Holdings Co., Ltd. (FRA:OS1)

Market Cap	22.60B
Revenue (ttm)	14.79B
Net Income (ttm)	2.17B
Shares Out	n/a
EPS (ttm)	4.01
PE Ratio	10.43
Forward PE	n/a
Dividend	0.71 (1.74%)
Ex-Dividend Date	Dec 27, 2024

Volume	5
Average Volume	57
Open	41.40
Previous Close	41.40
Day's Range	41.40 - 41.40
52-Week Range	38.60 - 59.00
Beta	n/a
RSI	44.17
Earnings Date	Jul 31, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 35,338
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OS1

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY